31-45 of 1197
Off-Label Medicines in Fighting COVID-19 & Through the Years
COVID-19: On The FrontlinesOff-Label Medicines in Fighting COVID-19 & Through the Years
HHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities
The Drug ReportHHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities
Drug Shortages During the COVID-19 Pandemic
The Drug ReportDrug Shortages During the COVID-19 Pandemic
Novel Therapeutic & Prevention Approaches to the Novel Coronavirus
The Drug ReportNovel Therapeutic & Prevention Approaches to the Novel Coronavirus
Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
The Drug ReportUncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial
- advertisement
A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
The Drug ReportA Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
REMS-Required Drug Monitoring During the COVID-19 Pandemic
The Drug ReportREMS-Required Drug Monitoring During the COVID-19 Pandemic
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
The Drug ReportRenin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
The Drug ReportCDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19
Update on Remdesivir, Investigational Antiviral for COVID-19
The Drug ReportUpdate on Remdesivir, Investigational Antiviral for COVID-19
A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
The Drug ReportA Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease
- advertisement
A New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs
The Drug ReportA New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs
Therapies & Vaccines on the Horizon for COVID-19
The Drug ReportTherapies & Vaccines on the Horizon for COVID-19
COVID-19 & the Economy: What Can We Expect?
Public Health On CallCOVID-19 & the Economy: What Can We Expect?





































